| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |